Key result
Cardiac myosin autoantibodies linked to myocardial inflammation, structural changes, and dysfunction in chronic myocarditis.
Observational (n=52)
In patients with chronic myocarditis, autoantibodies to cardiac myosin are associated with myocardial inflammation, structural remodeling, and cardiac dysfunction.
Answers are grounded in this paper and cite their sources.
May aid risk stratification in chronic myocarditis; leaves open causal role and therapeutic implications.
Evidence that has been progressively gathered implicates an important role of the immune system in the course of heart failure. In the majority of heart disease patients, disturbances of humoral immunity with production of cardiodepressant antibodies may play a functional role in cardiac dysfunction. This study evaluates the role of autoantibodies to the cardiac myosin. We examined 52 patients (from 14 till 61 years) with chronic myocarditis. The main examination methods were clinical and biochemical blood tests, ECG, ambulatory Holter ECG monitoring, echocardiography. Autoantibodies to the cardiac myosin were determined by ELISA. These autoantibodies correlate with myocardial inflammation. Also they are associated with structural changes of the heart (hypertrophy, dilation) and cardiac dysfunction (contractility, rhythm and conduction). The degree of expression of these disorders is related to the severity of chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Гладышева et al. (2013) conducted an observational in chronic myocarditis (n=52). Autoantibodies to cardiac myosin was evaluated on Myocardial inflammation, structural changes, and cardiac dysfunction. Autoantibodies to cardiac myosin correlated with myocardial inflammation, structural changes, and cardiac dysfunction in 52 patients with chronic myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: